User Fees Reauthorized for FDA
FDA keeps its user fees but fails to gain important reforms.
Congress moves promptly to finalize FDA user fees
House and Senate leaders announced final agreement June 18 on legislation that authorizes industry user fees to support FDA regulatory programs.